- Positive Expiratory Pressure (PEP)
- Oscillatory Positive Expiratory Pressure (OPEP)
- High Frequency Chest Wall Compression
- Intrapulmonary Percussive Ventilation flutter
- Incentive spirometry
- Mechanical Cough Assist
Airway Clearance Devices Market size was valued USD 539.6 million in 2021 and is expected to reach USD 786.2 million by 2028, at a CAGR of 6.2% during the forecast period 2022-2028 owing to increase in the prevalence of respiratory diseases all over the world. Rising incidences of respiratory diseases such as COPD, asthma, and other lung infections, and prevalence of diseases such as cystic fibrosis, chronic diffuse bronchiectasis, neuromuscular diseases and immotile ciliary dysfunction/primary ciliary dyskinesia. Airway clearance devices are used to clear out any infections present in the respiratory tract and make it clear without any obstacles. Additionally, due to the limitations of the earlier practice of traditional chest physiotherapy, high patient compliance to the respiratory clearance devices, lower costs and increased awareness are expected to enhance the sales of the market. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, global airway clearance devices market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed the market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product Opportunities).
Study Period
Base Year
CAGR
Largest Market
Fastest Growing Market
Increase in the prevalence of respiratory diseases like asthma, COPD, chronic diffuse bronchiectasis, and other respiratory diseases is a key factor drive the global airway clearance devices market. According to World Health Organization, approximately about 65 million people are suffering from COPD globally and it was the third leading reason of deaths all over the world. Increase in awareness regarding the devices, the raise in funding for the R&D activities by public and private sectors, advantages of using these devices over conventional chest physiotherapy are anticipated to propel the global artificial joints market over the forecast years
The Airway Clearance Devices Market is projected to expand at a CAGR of 6.3% during the forecast period.
Hill-Rom Holdings, Inc., Aptalis Pharma US,Inc., Thayer Medical, Electromed Inc., Breas Medical, General Physiotherapy, Inc.
Asia-Pacific is the fastest-growing region for Airway Clearance Devices Market